Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: AEGERION PHARMACEUTICALS A NOVELION THERAPEUTICS COMPANY
Client-Reported Lobbying Expenses
$378K
12 filings
Firm Income Reported for This Client
$125K
Not substituted for client expenses
Summary
AEGERION PHARMACEUTICALS A NOVELION THERAPEUTICS COMPANY is an organization, based in MA. Its political footprint includes $378K in client-reported lobbying expenses, $125K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Medicare/Medicaid. Political activity spans from 2017 to 2018.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↓ 100% YoY
2018: — (complete years)
Activity data: Senate LDA